Dizal (Jiangsu) Pharmaceutical Co., Ltd. Stock
Equities
688192
CNE1000055W8
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
44.39 CNY | +3.26% | +25.40% | -7.23% |
Sales 2023 | 91.29M 12.6M | Sales 2024 * | 490M 67.62M | Capitalization | 18.45B 2.55B |
---|---|---|---|---|---|
Net income 2023 | -1.12B -155M | Net income 2024 * | -649M -89.57M | EV / Sales 2023 | 214 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 37.7 x |
P/E ratio 2023 |
-17.4
x | P/E ratio 2024 * |
-28.5
x | Employees | 424 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 18.48% |
1 day | +3.26% | ||
1 week | +25.40% | ||
Current month | -1.33% | ||
1 month | +1.35% | ||
3 months | +20.01% | ||
6 months | +23.89% | ||
Current year | -7.23% |
Managers | Title | Age | Since |
---|---|---|---|
Xiao Lin Zhang
CEO | Chief Executive Officer | 60 | 17-10-26 |
Wei Wen Dong
CHM | Chairman | 38 | 18-05-31 |
Hong Bin Lu
DFI | Director of Finance/CFO | 46 | 20-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Lü
BRD | Director/Board Member | 56 | 17-09-30 |
Xue Gong Wang
BRD | Director/Board Member | 52 | 20-09-06 |
Guan Shan Zhu
BRD | Director/Board Member | 60 | 20-09-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 44.39 | +3.26% | 2,087,549 |
24-04-25 | 42.99 | +1.92% | 2,988,799 |
24-04-24 | 42.18 | +0.86% | 2,589,122 |
24-04-23 | 41.82 | +10.99% | 3,851,922 |
24-04-22 | 37.68 | +6.44% | 2,325,619 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.23% | 2.55B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 688192 Stock